Speakers
Souvik Biswas
Director, Discovery
Verve Therapeutics
Yogev Debbi
Co-Founder & CEO
Mana.bio
Yogev Debbi is a Co-founder and CEO of Mana.bio. Mana.bio is an AI based drug delivery startup, leveraging machine learning and AI in order to identify formulations of lipid nanoparticles drug delivery systems. Prior to that, Yogev was a Co-founder and COO of Genome Compiler, a leading gene editing platform that was acquired by Twist Bioscience, a global leader in synthetic biology. Following the acquisition, Yogev was the General Manager of the Israel R&D center and took part of Twist IPO. Yogev is very excited about the integration of software and machine learning with biology and is eager to leverage the integration of these two fields in order to bring disruptive products for improving health and quality of life.
Day One
Wednesday July 20, 2022
8:50 am | Opening Remarks
David Cipolla
VP of Research
Insmed
Day One
Wednesday July 20, 2022
3:15 pm | Formulation & Delivery Challenges with Inhaled Lipid Nanoparticle Formulations
Vincent Nebot
Chief Technical Officer
Polypeptide Therapeutic Solutions (PTS)
Day One
Wednesday July 20, 2022
11:30 am | Polymer Lipid Hybrids: A Chemical Toolbox for LNP Formulations
Bryant Nelson
Staff Research Chemist
National Institute of Standards & Technology
Dr. Shan Zou
Senior Research Officer, Team Leader for Nanoscale Measurement Disciplines; Adjunct Professor of Chemistry
Metrology Research Centre of the National Research Council Canada (NRC); Carleton University
Anitha Thomas
Director, Delivery
Precision Nanosystems
Day One
Wednesday July 20, 2022
12:10 pm | Novel Ionizable Lipid Library for Enabling Non-Viral Delivery
1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver
Priya Karmali
Chief Technology Officer
Capstan Therapeutics
Day One
Wednesday July 20, 2022
4:45 pm | Closing Remarks & End of Day One
9:10 am | Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies
8:50 am | Opening Remarks
John Lewis
Founder & Chief Executive Officer
Entos Pharmaceuticals
Day Two
Thursday 21 July 2022
10:00 am | Fireside Chat
9:00 am | Exploring a Next-Gen Delivery Platform for Targeted Delivery: Fusogenix Proteo-Lipid Vehicle (PLV)
Chun-Wan Yen
Principal Scientist
Genentech
Day Two
Thursday 21 July 2022
2:00 pm | Predictive High-Throughput Screening of Oligonucleotide Lipid Nanoparticles
Cory Sago
Senior Director & Head of LNP Discovery
Beam Therapeutics
Day One
Wednesday July 20, 2022
1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver
Day Two
Thursday 21 July 2022
10:00 am | Fireside Chat
9:30 am | Multiplexed Screening of LNPs in Vivo Enabled by Nucleic Acid Barcoding
Dominik Witzigmann
Co-Founder & Chief Executive Officer
Nanovation Therapeutics
Day One
Wednesday July 20, 2022
4:45 pm | Closing Remarks & End of Day One
11:40 am | Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery
Hemant Kumar
Chief Technology & Manufacturing Officer
Genprex
Hila Epstein-Barash
Chief Technology Officer & Co-Founder
Potentia Therapeutics
Day One
Wednesday July 20, 2022
1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver
James Ferguson
Chief Medical Officer
Matinas BioPharma
Day One
Wednesday July 20, 2022
9:40 am | Expanding Current Capabilities for Intracellular Drug Delivery with a Lipid Nano-Crystal (LNC) Platform
Day Two
Thursday 21 July 2022
2:15 pm | Chair’s Closing Remarks & End of Summit
10:00 am | Fireside Chat
8:50 am | Chair’s Opening Remarks
Kalina Paunovska
Postdoctoral Scholar Dahlman Lab
Georgia Institute of Technology
Day One
Wednesday July 20, 2022
2:15 pm | Using High-Throughput LNP Screening to Identify Novel Non-Liver Delivery Vehicles
Ruchi Shah
Associate Director, New Therapeutic Modalities
Eli Lily
Day Two
Thursday 21 July 2022
11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration
Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca
Day One
Wednesday July 20, 2022
4:15 pm | Spray Drying of Lipid Nanoparticles Enables Intratracheal Delivery
Sonya Zabludoff
Vice President, Clinical Development
Nitto BioPharma
Day One
Wednesday July 20, 2022
3:45 pm | Roundtable: Elevating Patient Centric Administration
Day Two
Thursday 21 July 2022
1:30 pm | Elevating Clinical Design for a Lipid Nanoparticle Candidate
Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis
Day Two
Thursday 21 July 2022
11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration
Qiaobing Xu
Founder & Chief Executive Officer
Hopewell Therapeutics
Rajesh Shinde
Senior Director of Manufacturing & Technology Operations
Genprex
Xiuling Lu
Associate Professor
University of Connecticut